Literature DB >> 25812999

Long-term persistence of a multi-resistant methicillin-susceptible Staphylococcus aureus (MR-MSSA) clone at a university hospital in southeast Sweden, without further transmission within the region.

M Lindqvist1, B Isaksson, J Swanberg, R Skov, A R Larsen, J Larsen, A Petersen, A Hällgren.   

Abstract

The objective of this study was to characterise isolates of methicillin-susceptible Staphylococcus aureus (MSSA) with resistance to clindamycin and/or tobramycin in southeast Sweden, including the previously described ECT-R clone (t002) found in Östergötland County, focusing on clonal relatedness, virulence determinants and existence of staphylococcal cassette chromosome (SCC) mec remnants. MSSA isolates with resistance to clindamycin and/or tobramycin were collected from the three county councils in southeast Sweden and investigated with spa typing, polymerase chain reaction (PCR) targeting the SCCmec right extremity junction (MREJ) and DNA microarray technology. The 98 isolates were divided into 40 spa types, and by microarray clustered in 17 multi-locus sequence typing (MLST) clonal complexes (MLST-CCs). All isolates with combined resistance to clindamycin and tobramycin (n = 12) from Östergötland County and two additional isolates (clindamycin-R) were designated as spa type t002, MREJ type ii and were clustered in CC5, together with a representative isolate of the ECT-R clone, indicating the clone's persistence. These isolates also carried several genes encoding exotoxins, Q9XB68-dcs and qacC. Of the isolates in CC15, 83% (25/30) were tobramycin-resistant and were designated spa type t084. Of these, 68% (17/25) were isolated from new-borns in all three counties. The persistence of the ECT-R clone in Östergötland County, although not found in any other county in the region, carrying certain virulence factors that possibly enhance its survival in the hospital environment, highlights the fact that basic hygiene guidelines must be maintained even when MRSA prevalence is low.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25812999     DOI: 10.1007/s10096-015-2366-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Quantifying interhospital patient sharing as a mechanism for infectious disease spread.

Authors:  Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

2.  Dispersal of antibiotic-resistant high-risk clones by hospital networks: changing the patient direction can make all the difference.

Authors:  T Donker; J Wallinga; H Grundmann
Journal:  J Hosp Infect       Date:  2013-09-24       Impact factor: 3.926

3.  An outbreak of a multiresistant methicillin-susceptible Staphylococcus aureus (MR-MSSA) strain in a burn centre: the importance of routine molecular typing.

Authors:  S A Boers; I van Ess; S M Euser; R Jansen; F R H Tempelman; B M W Diederen
Journal:  Burns       Date:  2011-02-19       Impact factor: 2.744

4.  Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005.

Authors:  Miriam Wiese-Posselt; Dagmar Heuck; Andreas Draeger; Martin Mielke; Wolfgang Witte; Andrea Ammon; Osamah Hamouda
Journal:  Clin Infect Dis       Date:  2007-04-25       Impact factor: 9.079

5.  A clonal outbreak of methicillin-susceptible Staphylococcus aureus with concomitant resistance to erythromycin, clindamycin and tobramycin in a Swedish county.

Authors:  Maria Lindqvist; Barbro Isaksson; Annika Samuelsson; Lennart E Nilsson; Anita Hallgren
Journal:  Scand J Infect Dis       Date:  2009

6.  New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci.

Authors:  A Huletsky; R Giroux; V Rossbach; M Gagnon; M Vaillancourt; M Bernier; F Gagnon; K Truchon; M Bastien; F J Picard; A van Belkum; M Ouellette; P H Roy; M G Bergeron
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition.

Authors:  Stefan Monecke; Peter Slickers; Ralf Ehricht
Journal:  FEMS Immunol Med Microbiol       Date:  2008-05-27

8.  Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.

Authors:  K R Fiebelkorn; S A Crawford; M L McElmeel; J H Jorgensen
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus.

Authors:  Stefan Monecke; Geoffrey Coombs; Anna C Shore; David C Coleman; Patrick Akpaka; Michael Borg; Henry Chow; Margaret Ip; Lutz Jatzwauk; Daniel Jonas; Kristina Kadlec; Angela Kearns; Frederic Laurent; Frances G O'Brien; Julie Pearson; Antje Ruppelt; Stefan Schwarz; Elizabeth Scicluna; Peter Slickers; Hui-Leen Tan; Stefan Weber; Ralf Ehricht
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

10.  Hospital networks and the dispersal of hospital-acquired pathogens by patient transfer.

Authors:  Tjibbe Donker; Jacco Wallinga; Richard Slack; Hajo Grundmann
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

View more
  1 in total

Review 1.  Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.

Authors:  Parisa Asadollahi; Narges Nodeh Farahani; Mehdi Mirzaii; Seyed Sajjad Khoramrooz; Alex van Belkum; Khairollah Asadollahi; Masoud Dadashi; Davood Darban-Sarokhalil
Journal:  Front Microbiol       Date:  2018-02-12       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.